Planta Med 2002; 68(5): 416-419
DOI: 10.1055/s-2002-32087
Original Paper
Pharmacology
© Georg Thieme Verlag Stuttgart · New York

In Vitro Antimycobacterial and Antilegionella Activity of Licochalcone A from Chinese Licorice Roots

Alice Friis-Møller1 , Ming Chen2 , Kurt Fuursted3 , Søren Brøgger Christensen4 , Arsalan Kharazmi2
  • 1Department of Clinical Microbiology, Hvidovre Hospital, Copenhagen, Denmark
  • 2Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark
  • 3Statens Serum Institut, Copenhagen, and Department of Clinical Microbiology, Aarhus,Denmark
  • 4Department of Medicinal Chemistry, Royal Danish School of Pharmacy, Copenhagen, Denmark
Further Information

Publication History

July 10, 2001

December 2, 2001

Publication Date:
07 June 2002 (online)

Zoom Image

Abstract

Licochalcone A, extracted and purified from Chinese licorice roots, showed in vitro inhibitory effect on human pathogenic Mycobacteria species and Legionella species. M. tuberculosis, M. bovis and BCG were inhibited by < 20 mg/l licochalcone A, whereas all non-M. tuberculosis complex species were resistant to > 20 mg/l Legionella pneumophila (serogroups 1 - 7) and L. bozemanii, L. dumoffii, L. feelei, L. longbeacheae and L. wadsworthii were inhibited by licochalcone A 1 - 4 mg/l, whereas L. gormanii and L. micdadei were inhibited by licochalcone A 500 - 1000 mg/l. These data indicate that licochalcone A might be of interest as a new class of antibacterial drug in the treatment of severe lung-infections.